Intuitive Surgical (ISRG) Stock Forecast & Price Target

$438.10 0.00 (0.00%)

Closing price 05/22/2026 04:00 PM Eastern

Extended Trading

$437.33 -0.77 (-0.18%)

As of 05/22/2026 08:00 PM Eastern

Compare

Intuitive Surgical - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 27 Analyst Ratings

Sell
1

Hold
7

Buy
19

Based on 27 Wall Street analysts who have issued ratings for Intuitive Surgical in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 27 analysts, 1 has given a sell rating, 7 have given a hold rating, and 19 have given a buy rating for ISRG.

Consensus Price Target

$579.33
32.24% Upside

According to the 27 analysts' twelve-month price targets for Intuitive Surgical, the average price target is $579.33. The highest price target for ISRG is $750.00, while the lowest price target for ISRG is $440.00. The average price target represents a forecasted upside of 32.24% from the current price of $438.10.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for ISRG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Intuitive Surgical and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ISRG Analyst Ratings Over Time

Type	Current Forecast 5/26/25 to 5/26/26	1 Month Ago 4/26/25 to 4/26/26	3 Months Ago 2/25/25 to 2/25/26	1 Year Ago 5/26/24 to 5/26/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	2 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	19 Buy rating(s)	18 Buy rating(s)	15 Buy rating(s)	15 Buy rating(s)
Hold	7 Hold rating(s)	7 Hold rating(s)	7 Hold rating(s)	5 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$579.33	$581.91	$615.86	$596.05
Forecasted Upside	32.24% Upside	20.67% Upside	21.67% Upside	10.47% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

ISRG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ISRG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Intuitive Surgical Stock vs. The Competition

Type	Intuitive Surgical	Medical Companies	Broader Market
Consensus Rating Score	2.67	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	32.24% Upside	1,718.94% Upside	15.09% Upside
News Sentiment Rating	Positive News See Recent ISRG News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/19/2026	Weiss Ratings Not Rated		Reiterated Rating	Hold (C)
5/18/2026	Bank of America 4 of 5 stars	Travis Steed Not Rated	Lower Target	Buy	$650.00 ➝ $520.00	+19.00%
4/23/2026	Barclays 3 of 5 stars	Matt Miksic 2 of 5 stars	Set Target	Overweight	$712.00 ➝ $651.00	+34.61%
4/22/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$653.00 ➝ $604.00	+24.69%
4/22/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Rescott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$575.00 ➝ $610.00	+25.19%
4/22/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Roman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$609.00 ➝ $621.00	+29.02%
4/22/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Hold	$560.00 ➝ $515.00	+7.00%
4/22/2026	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Outperform	$615.00 ➝ $577.00	+19.88%
4/22/2026	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Kratky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$622.00 ➝ $573.00	+19.05%
4/22/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Overweight	$625.00 ➝ $550.00	+14.27%
Get the Latest News and Ratings for ISRG and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Intuitive Surgical and its competitors with MarketBeat's FREE daily newsletter.
4/22/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$660.00 ➝ $585.00	+21.39%
4/22/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Maeder Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$620.00 ➝ $580.00	+28.52%
4/22/2026	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$574.00	+27.19%
4/15/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Newitter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$650.00 ➝ $580.00	+22.64%
4/13/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Petrone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Neutral	$575.00 ➝ $525.00	+16.37%
4/6/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Neutral	$550.00 ➝ $480.00	+5.86%
3/30/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
3/17/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andre Salles Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$570.00 ➝ $550.00	+13.12%
3/11/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$590.00	+21.44%
2/4/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$630.00 ➝ $560.00	+17.03%
1/23/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lee Hambright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$740.00 ➝ $750.00	+42.64%
12/17/2025	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shagun Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$625.00 ➝ $650.00	+17.21%
12/12/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Larry Biegelsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$600.00 ➝ $654.00	+19.48%
10/24/2025	Daiwa Securities Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Outperform	$510.00 ➝ $550.00	+0.28%
10/23/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$610.00 ➝ $615.00	+16.69%
8/22/2025	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Sell
7/23/2025	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
1/27/2025	CICC Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Neutral	$550.00	-4.17%
1/27/2025	Bernstein Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Overweight	$655.00 ➝ $700.00	+22.16%
12/5/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$525.00 ➝ $610.00	+11.22%
12/2/2024	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Equal Weight ➝ Overweight	$522.00 ➝ $650.00	+19.93%
10/18/2024	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 02:13 AM ET.

Should I Buy Intuitive Surgical Stock? ISRG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, May 19, 2026. Please send any questions or comments about these Intuitive Surgical pros and cons to contact@marketbeat.com.

Intuitive Surgical
Bull Case

Here are some ways that investors could benefit from investing in Intuitive Surgical, Inc.:

The company recently reported strong quarterly earnings, with earnings per share significantly exceeding analysts' expectations, indicating robust financial health and operational efficiency.
Intuitive Surgical, Inc. has demonstrated impressive revenue growth, with a year-over-year increase of 23%, showcasing its expanding market presence and demand for its products.
The current stock price is around $421, which may present a buying opportunity for investors looking to enter at a lower price point compared to its 52-week high.
Analysts have a consensus rating of "Moderate Buy" for the stock, with many investment firms raising their price targets, suggesting positive future performance.
The company is a leader in robotic-assisted surgical systems, particularly with its latest da Vinci surgical systems, which enhance precision and control in minimally invasive surgeries, appealing to hospitals and surgical centers.

Intuitive Surgical
Bear Case

Investors should be bearish about investing in Intuitive Surgical, Inc. for these reasons:

The stock has a high price-to-earnings (P/E) ratio, indicating that it may be overvalued compared to its earnings, which could deter value-focused investors.
Recent fluctuations in stock price have shown volatility, with a beta of 1.51, suggesting that the stock is more volatile than the market, which could pose risks for conservative investors.
Some analysts have lowered their price targets, indicating potential concerns about future growth or market conditions that could impact the company's performance.
Insider ownership is relatively low at 0.60%, which may raise questions about the confidence of those closest to the company in its future prospects.
As a technology company, Intuitive Surgical, Inc. faces significant competition and the need for continuous innovation, which can be costly and may impact profit margins.

ISRG Forecast - Frequently Asked Questions

According to the research reports of 27 Wall Street equities research analysts, the average twelve-month stock price forecast for Intuitive Surgical is $579.33, with a high forecast of $750.00 and a low forecast of $440.00.

27 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Intuitive Surgical in the last year. There is currently 1 sell rating, 7 hold ratings and 19 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ISRG shares.

According to analysts, Intuitive Surgical's stock has a predicted upside of 32.24% based on their 12-month stock forecasts.

Over the previous 90 days, Intuitive Surgical's stock had 1 upgrade and 1 downgrade by analysts.

Intuitive Surgical has been rated by research analysts at Bank of America, Barclays, BTIG Research, Citigroup, Evercore, HSBC, Jefferies Financial Group, JPMorgan Chase & Co., Leerink Partners, Mizuho, Piper Sandler, Raymond James Financial, Robert W. Baird, TD Cowen, The Goldman Sachs Group, Truist Financial, UBS Group, Weiss Ratings, and Zacks Research in the past 90 days.

Analysts like Intuitive Surgical more than other "medical" companies. The consensus rating for Intuitive Surgical is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how ISRG compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Intuitive Surgical Recommendations

This page (NASDAQ:ISRG) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

ISRG Analyst Ratings Over Time

ISRG Analyst Recommendations By Month

ISRG Price Targets by Month

Intuitive Surgical Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Intuitive Surgical Stock? ISRG Pros and Cons Explained

Intuitive Surgical
Bull Case

Intuitive Surgical
Bear Case

ISRG Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Intuitive Surgical Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

ISRG Analyst Ratings Over Time

ISRG Analyst Recommendations By Month

ISRG Price Targets by Month

Intuitive Surgical Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Intuitive Surgical Stock? ISRG Pros and Cons Explained

Intuitive Surgical Bull Case

Intuitive Surgical Bear Case

ISRG Forecast - Frequently Asked Questions

What is Intuitive Surgical's forecast for 2026?

Should I buy or sell Intuitive Surgical stock right now?

Does Intuitive Surgical's stock price have much upside?

Has Intuitive Surgical been upgraded or downgraded by Wall Street analysts recently?

What analysts cover Intuitive Surgical?

Do Wall Street analysts like Intuitive Surgical more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Intuitive Surgical Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Intuitive Surgical
Bull Case

Intuitive Surgical
Bear Case